Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments. The company was founded on February 27, 2014, and is headquartered in Wuxi, China.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
13,252
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Wuxi Biologics (Cayman) Inc. market cap is $24.36B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Wuxi Biologics (Cayman) Inc. 52 week high is $7.49 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Wuxi Biologics (Cayman) Inc. 52 week low is $3.90 as of November 18, 2026.
Wuxi Biologics (Cayman) Inc. stock price today is $5.49.
Wuxi Biologics (Cayman) Inc. stock price yesterday was $5.97.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Wuxi Biologics (Cayman) Inc.'s P/E ratio is 34.31.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Wuxi Biologics (Cayman) Inc. P/B ratio is 3.4603.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Wuxi Biologics (Cayman) Inc. 50-day moving average is $6.25.
Wuxi Biologics (Cayman) Inc. has 13,252 employees.